Tatva Chintan Pharma Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Strong revenue growth in the latest quarter reflects effective market positioning and increasing demand for specialty chemicals.
Improved profit margins indicate enhanced operational efficiency compared to previous quarters.
Consistent year-over-year growth signals robust business fundamentals and investor confidence.

NEGATIVES

Rising raw material costs have pressured profit margins and could impact future profitability.
Increased competition in the specialty chemicals sector may affect market share and pricing power.
Regulatory challenges could pose risks to operational stability and expansion plans.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25
Revenue	114.36	96.67	84.21	98.27	105.46	83.49	85.90	107.86	116.86	123.52
Expenses	93.02	76.42	73.21	82.66	92.85	77.90	78.84	98.91	99.53	101.30
Operating Profit	21.34	20.25	10.99	15.61	12.62	5.59	7.06	8.95	17.33	22.22
Other Income	1.02	0.76	1.21	4.53	1.17	0.38	0.04	0.72	1.16	1.01
Interest	2.93	3.01	0.38	0.21	0.31	0.17	0.42	0.39	0.41	0.51
Depreciation	6.01	6.78	6.58	6.23	6.67	6.81	6.92	7.26	8.97	9.05
Profit Before Tax	13.42	11.21	5.24	13.69	6.81	-1.02	-0.24	2.03	9.10	13.66
Tax	3.92	3.43	1.79	4.08	1.60	-0.36	-0.37	1	2.45	3.75
Net Profit	9.50	7.78	3.45	9.61	5.21	-0.66	0.14	1.03	6.65	9.92
Eps in Rs	4.29	3.43	1.48	4.11	2.23	-0.29	0.06	0.44	2.84	4.24